PP2A catalytic subunit alpha is critically required for CD8
Apoptosis
Bacterial infections
CD8 T cells
Intestinal immunity
PP2A
Journal
European journal of immunology
ISSN: 1521-4141
Titre abrégé: Eur J Immunol
Pays: Germany
ID NLM: 1273201
Informations de publication
Date de publication:
28 Jul 2024
28 Jul 2024
Historique:
revised:
11
07
2024
received:
15
02
2024
accepted:
15
07
2024
medline:
29
7
2024
pubmed:
29
7
2024
entrez:
29
7
2024
Statut:
aheadofprint
Résumé
Although the functions of tyrosine phosphatases in T-cell biology have been extensively studied, our knowledge on the contribution of serine/threonine phosphatases in T cells remains poor. Protein phosphatase 2A (PP2A) is one of the most abundantly expressed serine/threonine phosphatases. It is important in thymocyte development and CD4
Identifiants
pubmed: 39072720
doi: 10.1002/eji.202451080
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2451080Subventions
Organisme : NIAMS NIH HHS
ID : AR077518
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : AI162678
Informations de copyright
© 2024 Wiley‐VCH GmbH.
Références
Zheng, M., Li, D., Zhao, Z., Shytikov, D., Xu, Q., Jin, X. et al., Protein phosphatase 2A has an essential role in promoting thymocyte survival during selection. Proc. Natl. Acad. Sci. USA. 2019. 116:12422–12427.
Xu, Q., Jin, X., Zheng, M., Rohila, D., Fu, G., Wen, Z. et al., Phosphatase PP2A is essential for TH17 differentiation. Proc. Natl. Acad. Sci. USA. 2019. 116:982–987.
Pan, W., Nagpal, K., Suárez‐Fueyo, A., Ferretti, A., Yoshida, N., Tsokos, M. G. et al., The regulatory subunit PPP2R2A of PP2A enhances Th1 and Th17 differentiation through activation of the GEF‐H1/RhoA/ROCK signaling pathway. J. Immunol. 2021. 206:1719–1728.
Apostolidis, S. A., Rodríguez‐Rodríguez, N., Suárez‐Fueyo, A., Dioufa, N., Ozcan, E., Crispín, J. C. et al., Phosphatase PP2A is requisite for the function of regulatory T cells. Nat. Immunol. 2016. 17:556–564.
Meidan, E., Li, H., Pan, W., Kono, M., Yu, S., Kyttaris, V. C. et al., Serine/threonine phosphatase PP2A is essential for optimal B cell function. JCI Insight. 2020. 5:e130655.
Xiao, G., Chan, L. N., Klemm, L., Braas, D., Chen, Z., Geng, H. et al., B‐cell‐specific diversion of glucose carbon utilization reveals a unique vulnerability in B cell malignancies. Cell 2018. 173:470–484.e18.
Crispín, JC., Apostolidis, S. A., Rosetti, F., Keszei, M., Wang, N., Terhorst, C. et al., Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL‐17‐dependent mechanism. J. Immunol. 2012. 188:3567–3571.
Katsiari, C. G., Protein phosphatase 2A is a negative regulator of IL‐2 production in patients with systemic lupus erythematosus. J. Clin. Invest. 2005. 115:3193–3204.
Jiang, Y., Jin, X., Chi, Z., Bai, Y., Manthiram, K., Mudd, P. et al., Protein phosphatase 2A propels follicular T helper cell development in lupus. J. Autoimmu.. 2023. 136:103028.
Eil, R., Vodnala, S. K., Clever, D., Klebanoff, C. A., Sukumar, M., Pan, J. H. et al., Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature. 2016. 537:539–543.
Yan, L., Mieulet, V., Burgess, D., Findlay, G. M., Sully, K., Procter, J. et al., PP2A T61 epsilon is an inhibitor of MAP4K3 in nutrient signaling to mTOR. Mol. Cell. 2010. 37:633–642.
Ho, W. S., Wang, H., Maggio, D., Kovach, J. S., Zhang, Q., Song, Q. et al., Pharmacologic inhibition of protein phosphatase‐2A achieves durable immune‐mediated antitumor activity when combined with PD‐1 blockade. Nat. Commun. 2018. 9:2126.
Rodríguez‐Rodríguez, N., Madera‐Salcedo, I. K., Cisneros‐Segura, J. A., García‐González, H. B., Apostolidis, S. A., Saint‐Martin, A. et al., Protein phosphatase 2A B55beta limits CD8+ T cell lifespan following cytokine withdrawal. J. Clin. Invest. 2020. 130:5989–6004.
Chuang, E., Fisher, T. S., Morgan, R. W., Robbins, M. D., Duerr, J. M., Vander Heiden, MG. et al., The CD28 and CTLA‐4 receptors associate with the serine/threonine phosphatase PP2A. Immunity. 2000. 13:313–322.
Parry, RV., Chemnitz, J. M., Frauwirth, KA., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V. et al., CTLA‐4 and PD‐1 receptors inhibit T‐cell activation by distinct mechanisms. Mol. Cell Biol. 2005. 25:9543–9553.
Cheroutre, H., Lambolez, F. and Mucida, D., The light and dark sides of intestinal intraepithelial lymphocytes. Nat. Rev. Immunol. 2011. 11:445–456.
Yang, K., Neale, G., Green, D. R., He, W. and Chi, H.. The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat. Immunol. 2011. 12:888–897.
Zeng, H. and Chi, H., mTOR and lymphocyte metabolism. Curr. Opin Immunol. 2013. 25:347–355.
Baroja, M. L., Vijayakrishnan, L., Bettelli, E., Darlington, P. J., Chau, TA., Ling, V. et al., Inhibition of CTLA‐4 function by the regulatory subunit of serine/threonine phosphatase 2A. J. Immunol. 2002. 168:5070–5078.
Cui, J., Wang, H., Medina, R., Zhang, Q., Xu, C., Indig, IH. et al., Inhibition of PP2A with LB‐100 enhances efficacy of CAR‐T cell therapy against glioblastoma. Cancers (Basel) 2020. 12:139.
Mumby, M., PP2A: unveiling a reluctant tumor suppressor. Cell. 2007. 130:21–24.
Chen, W., Gu, P., Jiang, X., Ruan, H. B., Li, C. and Gao, X., Protein phosphatase 2A catalytic subunit alpha (PP2Acalpha) maintains survival of committed erythroid cells in fetal liver erythropoiesis through the STAT5 pathway. Am. J. Pathol. 2011. 178:2333–2343.
Sheridan, B. S., Pham, Q. M., Lee, Y. T., Cauley, L. S., Puddington, L. and Lefrançois, L., Oral infection drives a distinct population of intestinal resident memory CD8(+) T cells with enhanced protective function. Immunity. 2014. 40:747–757.